Intrinsic Value of S&P & Nasdaq Contact Us

ProQR Therapeutics N.V. PRQR NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • NL • USD

SharesGrow Score
57/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.63
+82.4%

Over the last 12 months, insiders have made 10 transactions in PRQR stock — 0 buys (valued at RSU Award) and 0 sells (valued at RSU Award).

PRQR Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 0%
Sell 0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-18 Valerio Domenico Director Unknown 25,192 $2.02 $50.89K
2026-03-18 De Boer Daniel Anton Chief Executive Officer Unknown 595,644 $2.02 $1.2M
2026-03-18 Maier Martin Alexander Director Unknown 25,192 $2.02 $50.89K
2026-03-18 Carreno-gomez Begona Director Unknown 25,192 $2.02 $50.89K
2026-03-18 Platenburg Gerardus Johannes Chief Scientific Officer Unknown 186,139 $2.02 $376K
2026-03-18 Filius Bart Director Unknown 25,192 $2.02 $50.89K
2026-03-18 Heggie Theresa Director Unknown 25,192 $2.02 $50.89K
2026-03-18 Hom Dennis Chief Financial Officer Unknown 250,000 $2.02 $505K
2026-03-18 Lawton Alison Frances Director Unknown 25,192 $2.02 $50.89K
2026-03-18 Shannon James Samuel Director Unknown 25,192 $2.02 $50.89K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message